Veterinary Medicines

FRONTLINE TRI-ACT 405.6 MG / 3028.8 MG SPOT-ON SOLUTION FOR DOGS 40-60 KG

Authorised
  • Fipronil
  • Permethrin
Download as PDF

Product identification

Medicine name:
FRONTLINE TRI-ACT 405.6 MG / 3028.8 MG SPOT-ON SOLUTION FOR DOGS 40-60 KG
Frontline Tri-Act, täpilahus koertele 40-60 kg
Active substance:
  • Fipronil
  • Permethrin
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    405.60
    milligram(s)
    /
    1.00
    Pipette
  • Permethrin
    3028.80
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • Plastic card of 1 pipette containing 6 ml
  • Carton box of 6 pipettes containing 6 ml each
  • Carton box of 3 pipettes containing 6 ml each

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 2145
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0266/005
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 30/10/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."